Biocon, Amylin to jointly develop diabetes drugDevelopment and Commercialization Agreement • May 29th, 2022
Contract Type FiledMay 29th, 2022
Biocon, Amylin to jointly develop diabetes drugDevelopment and Commercialization Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021